about
Mono- and dual-targeting triplebodies activate natural killer cells and have anti-tumor activity in vitro and in vivo against chronic lymphocytic leukemia.CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons: Rapid way to detect EGFR and KRAS mutations.DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies.Antigen Loss Variants: Catching Hold of Escaping Foes.
P50
description
researcher ORCID ID = 0000-0003-2996-4682
@en
wetenschapper
@nl
name
Maulik Vyas
@ast
Maulik Vyas
@en
Maulik Vyas
@es
Maulik Vyas
@nl
type
label
Maulik Vyas
@ast
Maulik Vyas
@en
Maulik Vyas
@es
Maulik Vyas
@nl
prefLabel
Maulik Vyas
@ast
Maulik Vyas
@en
Maulik Vyas
@es
Maulik Vyas
@nl
P108
P106
P31
P496
0000-0003-2996-4682